Comprehensive identification of <i>FGFR1-4</i> alterations in 5 557 Chinese patients with solid tumors by next-generation sequencing.
Weiquan Gu, Jie Yang, Yong Wang, Jun Xu, Xiaoxuan Wang, Furong Du, Xiangjing Hu, Hao Guo, Chao Song, Rongjie Tao, Xuchao Zhang
Abstract
fusions may benefit from anlotinib.
Topics & Concepts
Fibroblast growth factor receptor 1Cancer researchCancerBreast cancerFibroblast growth factor receptor 4Fusion geneBiologyGeneGene duplicationFibroblast growth factor receptorMedicineFibroblast growth factorGeneticsReceptorFibroblast Growth Factor ResearchKruppel-like factors researchEpigenetics and DNA Methylation